48 related articles for article (PubMed ID: 34738241)
21. Nicotinic acetylcholine receptors: Therapeutic targets for novel ligands to treat pain and inflammation.
Hone AJ; McIntosh JM
Pharmacol Res; 2023 Apr; 190():106715. PubMed ID: 36868367
[TBL] [Abstract][Full Text] [Related]
22. Preparation of uniform-sized GeXIVA[1,2]-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency.
Li L; Li Z; Guo Y; Zhang K; Mi W; Liu J
Drug Deliv; 2022 Dec; 29(1):2283-2295. PubMed ID: 35866254
[TBL] [Abstract][Full Text] [Related]
23. A 4/8 Subtype α-Conotoxin Vt1.27 Inhibits N-Type Calcium Channels With Potent Anti-Allodynic Effect.
Wang S; Bartels P; Zhao C; Yousuf A; Liu Z; Yu S; Bony AR; Ma X; Dai Q; Sun T; Liu N; Yang M; Yu R; Du W; Adams DJ; Dai Q
Front Pharmacol; 2022; 13():881732. PubMed ID: 35754473
[TBL] [Abstract][Full Text] [Related]
24. Analgesic α-conotoxins modulate native and recombinant GIRK1/2 channels via activation of GABA
Bony AR; McArthur JR; Finol-Urdaneta RK; Adams DJ
Br J Pharmacol; 2022 Jan; 179(1):179-198. PubMed ID: 34599513
[TBL] [Abstract][Full Text] [Related]
25. α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABA
Castro J; Harrington AM; Garcia-Caraballo S; Maddern J; Grundy L; Zhang J; Page G; Miller PE; Craik DJ; Adams DJ; Brierley SM
Gut; 2017 Jun; 66(6):1083-1094. PubMed ID: 26887818
[TBL] [Abstract][Full Text] [Related]
26. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.
Luo S; Zhangsun D; Harvey PJ; Kaas Q; Wu Y; Zhu X; Hu Y; Li X; Tsetlin VI; Christensen S; Romero HK; McIntyre M; Dowell C; Baxter JC; Elmslie KS; Craik DJ; McIntosh JM
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4026-35. PubMed ID: 26170295
[TBL] [Abstract][Full Text] [Related]
27. γ-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic α-conotoxins.
Cuny H; de Faoite A; Huynh TG; Yasuda T; Berecki G; Adams DJ
J Biol Chem; 2012 Jul; 287(28):23948-57. PubMed ID: 22613715
[TBL] [Abstract][Full Text] [Related]
28. A novel α-conopeptide Eu1.6 inhibits N-type (Ca
Liu Z; Bartels P; Sadeghi M; Du T; Dai Q; Zhu C; Yu S; Wang S; Dong M; Sun T; Guo J; Peng S; Jiang L; Adams DJ; Dai Q
Sci Rep; 2018 Jan; 8(1):1004. PubMed ID: 29343689
[TBL] [Abstract][Full Text] [Related]
29. ɑO-Conotoxin GeXIVA isomers modulate N-type calcium (Ca
Yousuf A; Wu X; Bony AR; Sadeghi M; Huang YH; Craik DJ; Adams DJ
J Neurochem; 2022 Jan; 160(2):154-171. PubMed ID: 34738241
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2) calcium channels.
Adams DJ; Berecki G
Biochim Biophys Acta; 2013 Jul; 1828(7):1619-28. PubMed ID: 23380425
[TBL] [Abstract][Full Text] [Related]
31. Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels.
Adams DJ; Callaghan B; Berecki G
Br J Pharmacol; 2012 May; 166(2):486-500. PubMed ID: 22091786
[TBL] [Abstract][Full Text] [Related]
32. Analgesic conopeptides targeting G protein-coupled receptors reduce excitability of sensory neurons.
Sadeghi M; McArthur JR; Finol-Urdaneta RK; Adams DJ
Neuropharmacology; 2017 Dec; 127():116-123. PubMed ID: 28533165
[TBL] [Abstract][Full Text] [Related]
33. α-Conotoxin Peptidomimetics: Probing the Minimal Binding Motif for Effective Analgesia.
Kennedy AC; Belgi A; Husselbee BW; Spanswick D; Norton RS; Robinson AJ
Toxins (Basel); 2020 Aug; 12(8):. PubMed ID: 32781580
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
